Studying Preoperative Immunonutrition to Reduce Complications and Improve Immune Response After Cystectomy Surgery
Led by Centre Hospitalier Universitaire Vaudois · Updated on 2025-12-09
232
Participants Needed
4
Research Sites
8 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the effect of preoperative oral immunonutrition IN on reducing post-operative complications in patients undergoing cystectomy, a surgery to remove the bladder. This multicenter randomized controlled trial aims to assess whether IN can improve outcomes like infections after surgery and to develop a method to identify patients who would benefit most from this nutrition. The study addresses the high complication rates associated with cystectomy and the role of malnutrition as a risk factor.
Participants are randomly assigned to one of two groups one receives seven days of oral immunonutrition before surgery, and the other follows standard care without IN. The immunonutrition supplement, Oral Impact, is taken three times daily for seven days before the operation. The trial compares these approaches to see if preoperative IN reduces complications and improves immune response.
During the study, researchers will monitor infectious complications within 30 days after surgery as the primary outcome. Secondary outcomes include overall complication rates at 30 and 90 days, mortality rates, complication-free survival, and treatment compliance. Participants will be assessed through clinical evaluations and compliance tracking from 30 days before surgery through hospital admission. The total participation duration varies depending on surgery timing and follow-up assessments.
CONDITIONS
Brief Title
The Role of Preoperative Immunonutrition on Morbidity and Immune Response After Cystectomy (INCyst Trial)
Research Team
I
Ilaria Lucca, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Patient undergoing open cystectomy (for all reasons)
Age 318 years
Ability and willingness to provide informed consent documented by signature
You will not qualify if you...
Known allergy or hypersensitivity to lactose, fish oil, or soy lecithin
Severe diarrhea requiring medical attention
Current treatment with any immunosuppressive drug
Pregnancy or breastfeeding status
Presence of significant immune-related diseases such as severe renal failure, HIV, systemic lupus erythematosus, or organ transplant recipient
Inability to follow study procedures due to psychological disorders or dementia
Participation in another investigational drug study within 30 days before and during this study
Previous enrollment in this study
Use of immunonutrition independently of the study
Enrollment of the investigator, family members, employees, or dependents
Emergency surgery with less than 7 days between screening and operation
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Run-in Period
Duration - 7 days preoperatively
Participants take preoperative immunonutrition supplementation to improve nutritional and immune status before surgery.
Daily intake of oral supplementation for 7 days
Surgery and Immediate Post-operative Care
Duration - Hospital stay following surgery
Participants undergo open cystectomy surgery with immediate postoperative care.
Hospital visits during surgical admission
Post-operative Follow-up
Duration - Up to 90 days after surgery
Participants are monitored for complications, recovery, and survival after surgery.
Follow-up visits or contacts up to 90 days post-surgery
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Similar Trials
Evaluation of 18FFAPI-74 PET Imaging Compared to Standard Methods for Detecting Multiple Cancer Types
Bladder-Sparing Treatment Approach for Large Non-Muscle-Invasive Bladder Cancer
Comparing Maximal TURBT with Chemotherapy and Immunotherapy Versus Immediate Radical Cystectomy
Phase 12 Study Evaluating Intravesical MK-3120 for High-Risk Non-Muscle Invasive Bladder Cancer After Tumor Removal
Phase 3 Study Comparing Sacituzumab Tirumotecan to Non-Platinum Chemotherapy in Advanced Urothelial Cancer
Phase 1 Study of Intratumoral ONM-501 Alone and with Cemiplimab for Advanced Solid Tumors and Lymphomas
Get Moving Trial Evaluating Home-Based Prehabilitation Exercise Using ExerciseRx App
for Bladder and Upper Tract Urothelial Cancer Patients Undergoing Surgery
Long-Term Study of Urothelial and Rare Genitourinary Tract Cancers to Understand Disease Progression and Treatment Responses
Validating a New Multiplex ELISA Urine Test for Detecting Bladder Cancer
in Adults with Microscopic Hematuria
Non-Invasive Multiplex ELISA Test to Monitor Patients with a History of Bladder Cancer
Long-Term Study of Relugolix Combination Tablet to Monitor Bone Health in Premenopausal Women With Heavy Menstrual Bleeding From Fibroids or Pain From Endometriosis
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
The role of preoperative immunonutrition on morbidity and immune response after cystectomy: protocol of a multicenter randomized controlled trial (INCyst Trial).